WigSuperstore.com can help you cope with hair loss
Find the wig or hairpiece that's right for you at WigSuperstore.com
If you're suffering from hair loss due to medical reasons such as Alopecia or radiation treatments, our versatile yet comfortable monofilament wigs or hand-tied wigs are perfect for sensitive skin. Choose from easy-to-care for synthetic wigs or natural-looking 100% human hair wigs.
Hundreds of Styles Available
Shop now and choose from hundreds of wig styles to create a look that's all your own. Whether you're looking for short hair, long hair, trendy styles or classic looks, Wigsuperstores.com has a wig for you and stocks famous brands such as Jon Renau, Revlon and Raquel Welch. Change your look with popular clip-on hair extensions.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
